Skip to content

The Disease Daily

  • About
    • Terms of Use
  • Authors
  • Categories
    • Commentary
    • DD on Take Part
    • Featured Series
    • Outbreak News
    • Research & Policy
    • The Script

Tag: VLA15

  • Home
  • VLA15
Research & Policy

Lyme Disease Vaccine Candidate VLA15 Advances Through Phase 1 Trials

July 16, 2018 Emily Wolfson

  Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,

Read More
Research & Policy

Lyme Disease Vaccine Candidate VLA15 Advances Through Phase 1 Trials

July 16, 2018 Emily Wolfson

  Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,

Read More

Recent Posts

  • Update on Ebola Outbreak in Uganda
  • Cholera Outbreak in Haiti – First in 3 Years
  • Poliovirus Spreading in the United States: New York Declares State of Emergency
  • Outbreak of Ebola Sudan Strain Declared in Uganda
  • The Increasing Incidence of Lyme Disease and Recent Fatal Cases of Powassan Virus in the Northeastern United States

Categories

  • Commentary
  • DD on Take Part
  • Featured Series
  • Outbreak News
  • Research & Policy
All Rights Reserved 2022.
Proudly powered by WordPress | Theme: Fairy by Candid Themes.